Jinling Pharmaceutical (000919.SZ): Termination of intention to acquire shares in Four Pharmaceutical Companies

Zhitong Finance App News, Jinling Pharmaceutical (000919.SZ) issued an announcement. The company submitted a “Letter of Intent to Invest” to Changzhou Siyao Pharmaceutical Co., Ltd. (“Siyao Company”) on April 13, 2026, indicating that the company and/or the entities participating in the company's control intend to acquire 100% of the shares of Siyao Company held by current shareholders of Siyao Company in cash.

Since submitting the “Letter of Intent to Invest” to Sipharmaceutical Company on April 13, 2026, the company has carried out due diligence, preliminary audits, asset evaluation, and transaction plan verification in an orderly manner, and has continued to communicate and negotiate with relevant parties on investment intentions. Recently, the company received an “Invitation Letter” from Si Pharmaceutical Co., Ltd., and 100% of Si Pharmaceutical Company's shares and part of the land and plant assets of the Si Pharmaceutical Factory are to be sold through bidding. According to materials such as the “Invitation Letter” received by the company and the “Bidding Operation Guidelines” attached to the letter, the company decided not to participate in this bidding activity and terminated the above investment intentions, taking into account the information already known earlier and after careful research.